0.0110USD-8.33%Mkt Cap: 2.79M $P/E: —15d ago
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operate…
Industry Peers
Diagnostics & Research$201.86BUSDP/E 29.8
$145.10BUSDP/E 39.7
$45.85BUSDP/E 44.2
$45.44BUSDP/E 42.4
$38.64BUSD
$38.44BUSDP/E 27.3
$37.13BUSDP/E 48.1
$35.13BUSDP/E 26.2
$28.78BUSDP/E 34.6
$26.98BUSDP/E 31.4
$23.18BUSDP/E 23.1
$23.12BUSDP/E 25.0
$20.55BUSD
$15.36BUSDP/E 33.9
$13.06BUSDP/E 27.3
$12.46BUSDP/E 53.7
$11.04BUSD
$9.26BUSDP/E 21.6
$5.90BUSDP/E 237.4
$5.68BUSD
$5.21BUSDP/E 44.6
$4.95BUSD
$4.73BUSDP/E 54.8
$3.75BUSDP/E 26.5
$3.54BUSD
$3.09BUSD
$2.08BUSD
$1.93BUSD
$1.83BUSD
$1.64BUSDP/E 41.7
$1.63BUSD
$1.48BUSDP/E 22.4
$1.02BUSDP/E 21.4
$898.56MUSD
$734.89MUSD
$616.40MUSDP/E 40.2
$584.63MUSD
$583.63MUSD
$293.12MUSDP/E 2.9
$292.75MUSD
$206.70MUSD
$152.09MUSD
$139.43MUSD
$97.25MUSD
$102.68MUSD
$89.37MUSDP/E 17.2
$73.19MUSD
$58.55MUSD
$42.32MUSD
$30.71MUSD
$26.61MUSD
$20.94MUSD
$16.60MUSD
$12.04MUSD
$9.95MUSD
$8.70MUSD
$8.87MUSD
$7.73MUSD
$7.43MUSD
$6.69MUSD
$6.06MUSD
$5.06MUSD
$4.47MUSD
$4.44MUSD
$2.95MUSD
$3.29MUSD
$3.18MUSD
$869.0KUSD
$314.2KUSDP/E Infinity
$19.6KUSD
Indicators:|
Key Statistics
Company
Market Cap2.79M $
Enterprise Value474.33M $
Revenue (TTM)507.36M $
Gross Profit120.98M $
Net Income (TTM)-68.63M $
Revenue/Share14.73 USD
Last Price0.0110 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees1.9K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS45783Q1004
Valuation
P/E (Trailing)—
P/E (Forward)-1.60
PEG—
EV/EBITDA55.42
EV/Revenue0.93
P/S0.01
P/B0.04
EPS (TTM)-2.48
EPS (Forward)-0.05
52W Range
0.00800% of range2.440
52W High2.440 USD
52W Low0.0080 USD
Profitability
Gross Margin23.58%
Oper. Margin-16.03%
EBITDA Margin1.69%
Profit Margin-13.38%
ROE-50.45%
ROA-8.90%
Growth
Revenue Growth-5.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.46M $
CapEx (TTM)16.61M $
FCF Margin4.66%
FCF Yield847.35%
Net Debt472.59M $
Net Debt/EBITDA55.22
Balance Sheet
Debt/Equity3.38
Current Ratio0.27
Quick Ratio0.15
Book Value/Sh2.210 USD
Cash/Share0.4350 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.34.89M
Float32.32M
Insiders8.64%
Institutions14.00%
Short Interest
Short Ratio3.2d
Short % Float7.86%
Short % Out.7.23%
Shares Short2.52M
Short (prev mo.)3.13M
Technical
SMA 500.2403 (-95.4%)
SMA 2000.6403 (-98.3%)
Beta3.77
S&P 52W Chg20.37%
Avg Vol (30d)5.01M
Avg Vol (10d)118.15M
Technical Indicators
RSI (14)26.4
MACD-0.0703
MACD Signal-0.0590
MACD Hist.-0.0113
BB Upper0.3643 USD
BB Middle0.1400 USD
BB Lower-0.0843 USD
BB Width320.50%
ATR (14)0.0352 USD
Vol Ratio (20d)0.03x